Daewoong Pharmaceutical Announces 2023 Financial Results - Thailand Business News
SEOUL, South Korea, Feb. 6, 2024 /PRNewswire/ -- Daewoong Pharmaceutical (KRX: 069620.KS), a global pharmaceutical company located in Seoul, announced its
South Korea United States Soult Ukpyolsi Fexuclue Fexuprazan Envlo Enavogliflozin Korean Ministry Of Food
Source: thailand-business-news.com